{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,21]],"date-time":"2026-10-21T03:06:10Z","timestamp":1792551970035,"version":"4.5.0"},"reference-count":73,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2024,5,1]],"date-time":"2024-05-01T00:00:00Z","timestamp":1714521600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,5,1]],"date-time":"2024-05-01T00:00:00Z","timestamp":1714521600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2024,5,1]],"date-time":"2024-05-01T00:00:00Z","timestamp":1714521600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2024,5,1]],"date-time":"2024-05-01T00:00:00Z","timestamp":1714521600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2024,5,1]],"date-time":"2024-05-01T00:00:00Z","timestamp":1714521600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2024,5,1]],"date-time":"2024-05-01T00:00:00Z","timestamp":1714521600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","theclinics.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinics in Liver Disease"],"published-print":{"date-parts":[[2024,5]]},"DOI":"10.1016\/j.cld.2024.01.004","type":"journal-article","created":{"date-parts":[[2024,2,8]],"date-time":"2024-02-08T14:51:26Z","timestamp":1707403886000},"page":"237-252","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":12,"title":["Minimal Hepatic Encephalopathy"],"prefix":"10.1016","volume":"28","author":[{"given":"Rachel","family":"Redfield","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nyan","family":"Latt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Santiago J.","family":"Munoz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"6","key":"10.1016\/j.cld.2024.01.004_bib1","doi-asserted-by":"crossref","first-page":"2014","DOI":"10.1002\/hep.23216","article-title":"Spectrum of neurocognitive impairment in cirrhosis: Implications for the assessment of hepatic encephalopathy","volume":"50","author":"Bajaj","year":"2009","journal-title":"Hepatology"},{"issue":"5","key":"10.1016\/j.cld.2024.01.004_bib2","doi-asserted-by":"crossref","first-page":"768","DOI":"10.1016\/S0168-8278(01)00026-5","article-title":"Neuropsychological characterization of hepatic encephalopathy","volume":"34","author":"Weissenborn","year":"2001","journal-title":"J\u00a0Hepatol"},{"issue":"7","key":"10.1016\/j.cld.2024.01.004_bib3","doi-asserted-by":"crossref","first-page":"739","DOI":"10.1111\/j.1365-2036.2011.04590.x","article-title":"Review article: the design of clinical trials in hepatic encephalopathy--an International Society for Hepatic Encephalopathy and Nitrogen Metabolism (ISHEN) consensus statement","volume":"33","author":"Bajaj","year":"2011","journal-title":"Aliment Pharmacol Ther"},{"issue":"13","key":"10.1016\/j.cld.2024.01.004_bib4","doi-asserted-by":"crossref","first-page":"3008","DOI":"10.1016\/j.cgh.2020.03.033","article-title":"Minimal hepatic encephalopathy and mild cognitive impairment worsen quality of life in Elderly patients with cirrhosis","volume":"18","author":"Bajaj","year":"2020","journal-title":"Clin Gastroenterol Hepatol"},{"issue":"4","key":"10.1016\/j.cld.2024.01.004_bib5","doi-asserted-by":"crossref","first-page":"1175","DOI":"10.1002\/hep.23128","article-title":"Minimal hepatic encephalopathy is associated with motor vehicle crashes: the reality beyond the driving test","volume":"50","author":"Bajaj","year":"2009","journal-title":"Hepatology"},{"issue":"23","key":"10.1016\/j.cld.2024.01.004_bib6","doi-asserted-by":"crossref","first-page":"3609","DOI":"10.3748\/wjg.14.3609","article-title":"Minimal hepatic encephalopathy matters in daily life","volume":"14","author":"Bajaj","year":"2008","journal-title":"World J Gastroenterol"},{"issue":"2","key":"10.1016\/j.cld.2024.01.004_bib7","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1002\/hep.27210","article-title":"Hepatic encephalopathy in chronic liver disease: 2014 practice guideline by the American association for the study of liver diseases and the European association for the study of the liver","volume":"60","author":"Vilstrup","year":"2014","journal-title":"Hepatology"},{"issue":"8","key":"10.1016\/j.cld.2024.01.004_bib8","doi-asserted-by":"crossref","first-page":"977","DOI":"10.1002\/lt.23909","article-title":"Cognitive impairment and electroencephalographic alterations before and after liver transplantation: what is reversible?","volume":"20","author":"Campagna","year":"2014","journal-title":"Liver Transpl"},{"issue":"4","key":"10.1016\/j.cld.2024.01.004_bib9","doi-asserted-by":"crossref","DOI":"10.1097\/HC9.0000000000000096","article-title":"Prediction and prevention of the first episode of overt hepatic encephalopathy in patients with cirrhosis","volume":"7","author":"Gairing","year":"2023","journal-title":"Hepatol Commun"},{"issue":"10","key":"10.1016\/j.cld.2024.01.004_bib10","doi-asserted-by":"crossref","first-page":"2704","DOI":"10.3748\/wjg.v20.i10.2704","article-title":"TIPS improves liver transplantation-free survival in cirrhotic patients with refractory ascites: an updated meta-analysis","volume":"20","author":"Bai","year":"2014","journal-title":"World J Gastroenterol"},{"issue":"4","key":"10.1016\/j.cld.2024.01.004_bib11","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1038\/ajg.2018.6","article-title":"Diagnosis of minimal hepatic encephalopathy: a systematic review of point-of-care diagnostic tests","volume":"113","author":"Tapper","year":"2018","journal-title":"Am J Gastroenterol"},{"issue":"7","key":"10.1016\/j.cld.2024.01.004_bib12","doi-asserted-by":"crossref","first-page":"989","DOI":"10.14309\/ajg.0000000000000603","article-title":"Important Unresolved questions in the management of hepatic encephalopathy: an ISHEN consensus","volume":"115","author":"Bajaj","year":"2020","journal-title":"Am J Gastroenterol"},{"issue":"5","key":"10.1016\/j.cld.2024.01.004_bib13","doi-asserted-by":"crossref","first-page":"398","DOI":"10.5152\/tjg.2019.18226","article-title":"Advances in psychometric tests for screening minimal hepatic encephalopathy: from paper-and-pencil to computer-aided assessment","volume":"30","author":"Luo","year":"2019","journal-title":"Turk J Gastroenterol"},{"issue":"8","key":"10.1016\/j.cld.2024.01.004_bib15","doi-asserted-by":"crossref","first-page":"1384","DOI":"10.1016\/j.cgh.2013.12.020","article-title":"Diagnosis of covert hepatic encephalopathy without specialized tests","volume":"12","author":"Nabi","year":"2014","journal-title":"Clin Gastroenterol Hepatol"},{"issue":"9","key":"10.1016\/j.cld.2024.01.004_bib14","doi-asserted-by":"crossref","first-page":"1353","DOI":"10.1002\/hep4.1555","article-title":"Validation of a simple quality-of-life score for Identification of minimal and prediction of overt hepatic encephalopathy","volume":"4","author":"Lauridsen","year":"2020","journal-title":"Hepatol Commun"},{"issue":"4","key":"10.1016\/j.cld.2024.01.004_bib16","doi-asserted-by":"crossref","first-page":"754","DOI":"10.1111\/j.1572-0241.2007.01048.x","article-title":"Inhibitory control test is a simple method to diagnose minimal hepatic encephalopathy and predict development of overt hepatic encephalopathy","volume":"102","author":"Bajaj","year":"2007","journal-title":"Am J Gastroenterol"},{"issue":"5","key":"10.1016\/j.cld.2024.01.004_bib17","doi-asserted-by":"crossref","first-page":"1591","DOI":"10.1053\/j.gastro.2008.07.021","article-title":"Inhibitory control test for the diagnosis of minimal hepatic encephalopathy","volume":"135","author":"Bajaj","year":"2008","journal-title":"Gastroenterology"},{"issue":"10","key":"10.1016\/j.cld.2024.01.004_bib18","doi-asserted-by":"crossref","first-page":"3645","DOI":"10.3390\/ijerph17103645","article-title":"Clinical Usefulness of the inhibitory control test (ICT) in the diagnosis of minimal hepatic encephalopathy","volume":"17","author":"Stawicka","year":"2020","journal-title":"Int J Environ Res Public Health"},{"issue":"7","key":"10.1016\/j.cld.2024.01.004_bib19","doi-asserted-by":"crossref","first-page":"697","DOI":"10.1037\/pas0001137","article-title":"A\u00a0comparison of embedded validity indicators from the Stroop Color and Word Test among adults referred for clinical evaluation of suspected or confirmed attention-deficit\/hyperactivity disorder","volume":"34","author":"Khan","year":"2022","journal-title":"Psychol Assess"},{"issue":"2","key":"10.1016\/j.cld.2024.01.004_bib20","doi-asserted-by":"crossref","first-page":"530","DOI":"10.1002\/hep.24704","article-title":"Patients with minimal hepatic encephalopathy show impaired mismatch negativity correlating with reduced performance in attention tests","volume":"55","author":"Felipo","year":"2012","journal-title":"Hepatology"},{"issue":"3","key":"10.1016\/j.cld.2024.01.004_bib21","doi-asserted-by":"crossref","first-page":"1122","DOI":"10.1002\/hep.26309","article-title":"The Stroop smartphone application is a short and valid method to screen for minimal hepatic encephalopathy","volume":"58","author":"Bajaj","year":"2013","journal-title":"Hepatology"},{"issue":"10","key":"10.1016\/j.cld.2024.01.004_bib22","doi-asserted-by":"crossref","first-page":"1828","DOI":"10.1016\/j.cgh.2014.05.011","article-title":"Validation of EncephalApp, smartphone-based Stroop test, for the diagnosis of covert hepatic encephalopathy","volume":"13","author":"Bajaj","year":"2015","journal-title":"Clin Gastroenterol Hepatol"},{"issue":"1","key":"10.1016\/j.cld.2024.01.004_bib23","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1038\/ajg.2015.377","article-title":"Diagnosis of minimal hepatic encephalopathy using Stroop EncephalApp: a multicenter US-based, Norm-based study","volume":"111","author":"Allampati","year":"2016","journal-title":"Am J Gastroenterol"},{"issue":"7","key":"10.1016\/j.cld.2024.01.004_bib24","doi-asserted-by":"crossref","first-page":"1556","DOI":"10.1111\/liv.14494","article-title":"Acceptance and use of a smartphone application in cirrhosis","volume":"40","author":"Louissaint","year":"2020","journal-title":"Liver Int"},{"issue":"1","key":"10.1016\/j.cld.2024.01.004_bib25","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1016\/j.cgh.2021.12.047","article-title":"QuickStroop, a shortened version of EncephalApp, detects covert hepatic encephalopathy with similar accuracy within one minute","volume":"21","author":"Acharya","year":"2023","journal-title":"Clin Gastroenterol Hepatol"},{"issue":"1","key":"10.1016\/j.cld.2024.01.004_bib26","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1002\/hep.29146","article-title":"The animal naming test: an easy tool for the assessment of hepatic encephalopathy","volume":"66","author":"Campagna","year":"2017","journal-title":"Hepatology"},{"issue":"1","key":"10.1016\/j.cld.2024.01.004_bib27","doi-asserted-by":"crossref","DOI":"10.14309\/ctg.0000000000000447","article-title":"Animal naming test is associated with poor patient-reported outcomes and frailty in people with and without cirrhosis: a prospective cohort study","volume":"13","author":"Tapper","year":"2022","journal-title":"Clin Transl Gastroenterol"},{"issue":"4","key":"10.1016\/j.cld.2024.01.004_bib28","doi-asserted-by":"crossref","first-page":"1498","DOI":"10.1002\/hep.29628","article-title":"A\u00a0risk score to predict the development of hepatic encephalopathy in a population-based cohort of patients with cirrhosis","volume":"68","author":"Tapper","year":"2018","journal-title":"Hepatology"},{"issue":"12","key":"10.1016\/j.cld.2024.01.004_bib29","doi-asserted-by":"crossref","first-page":"2017","DOI":"10.14309\/ajg.0000000000000762","article-title":"Incidence and Bedside Predictors of the first episode of overt hepatic encephalopathy in patients with cirrhosis","volume":"115","author":"Tapper","year":"2020","journal-title":"Am J Gastroenterol"},{"issue":"4","key":"10.1016\/j.cld.2024.01.004_bib30","doi-asserted-by":"crossref","DOI":"10.1145\/3531231","article-title":"Multimodal Fusion of smart home and Text-based behavior markers for clinical assessment prediction","volume":"3","author":"Sprint","year":"2022","journal-title":"ACM Trans Comput Healthc"},{"key":"10.1016\/j.cld.2024.01.004_bib31","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1038\/s41746-019-0179-9","article-title":"Language impairment in adults with end-stage liver disease: application of natural language processing towards patient-generated health records","volume":"2","author":"Dickerson","year":"2019","journal-title":"NPJ Digit Med"},{"issue":"10","key":"10.1016\/j.cld.2024.01.004_bib32","doi-asserted-by":"crossref","first-page":"2876","DOI":"10.1002\/hep4.2054","article-title":"Speech patterns and enunciation for encephalopathy determination-A prospective study of hepatic encephalopathy","volume":"6","author":"Moon","year":"2022","journal-title":"Hepatol Commun"},{"issue":"2","key":"10.1016\/j.cld.2024.01.004_bib33","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1016\/j.cld.2020.01.012","article-title":"Minimal hepatic encephalopathy","volume":"24","author":"Karanfilian","year":"2020","journal-title":"Clin Liver Dis"},{"issue":"2","key":"10.1016\/j.cld.2024.01.004_bib34","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1016\/j.cld.2021.01.008","article-title":"Diagnosis and management of hepatic encephalopathy","volume":"25","author":"Rudler","year":"2021","journal-title":"Clin Liver Dis"},{"issue":"3","key":"10.1016\/j.cld.2024.01.004_bib35","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1016\/j.mcna.2023.01.003","article-title":"Hepatic encephalopathy: diagnostic tools and management strategies","volume":"107","author":"Badal","year":"2023","journal-title":"Med Clin North Am"},{"issue":"2","key":"10.1016\/j.cld.2024.01.004_bib36","first-page":"142","article-title":"Hepatic encephalopathy: an Update on the Pathophysiology and therapeutic options","volume":"5","author":"Elwir","year":"2017","journal-title":"J\u00a0Clin Transl Hepatol"},{"issue":"2","key":"10.1016\/j.cld.2024.01.004_bib37","first-page":"CD003044","article-title":"Nonabsorbable disaccharides for hepatic encephalopathy","author":"Als-Nielsen","year":"2004","journal-title":"Cochrane Database Syst Rev"},{"issue":"4","key":"10.1016\/j.cld.2024.01.004_bib38","doi-asserted-by":"crossref","first-page":"800","DOI":"10.1016\/j.cgh.2019.08.047","article-title":"Comparative efficacy of treatment options for minimal hepatic encephalopathy: a systematic review and Network meta-analysis","volume":"18","author":"Dhiman","year":"2020","journal-title":"Clin Gastroenterol Hepatol"},{"issue":"4","key":"10.1016\/j.cld.2024.01.004_bib39","first-page":"325","article-title":"The effect of lactulose on psychomotor performance tests in alcoholic cirrhotics without overt hepatic encephalopathy","volume":"6","author":"McClain","year":"1984","journal-title":"J\u00a0Clin Gastroenterol"},{"issue":"6","key":"10.1016\/j.cld.2024.01.004_bib40","doi-asserted-by":"crossref","first-page":"1410","DOI":"10.1002\/hep.510260606","article-title":"Clinical efficacy of lactulose in cirrhotic patients with and without subclinical hepatic encephalopathy","volume":"26","author":"Watanabe","year":"1997","journal-title":"Hepatology"},{"issue":"3","key":"10.1016\/j.cld.2024.01.004_bib41","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1002\/hep.21533","article-title":"Lactulose improves cognitive functions and health-related quality of life in patients with cirrhosis who have minimal hepatic encephalopathy","volume":"45","author":"Prasad","year":"2007","journal-title":"Hepatology"},{"issue":"6","key":"10.1016\/j.cld.2024.01.004_bib42","first-page":"387","article-title":"A\u00a0non-absorbable rifamycin for treatment of hepatic encephalopathy","volume":"11","author":"Testa","year":"1985","journal-title":"Drugs Exp Clin Res"},{"issue":"4","key":"10.1016\/j.cld.2024.01.004_bib43","first-page":"257","article-title":"In\u00a0vitro and in\u00a0vivo evaluation of L\/105, a new topical intestinal rifamycin","volume":"5","author":"Venturini","year":"1986","journal-title":"Chemioterapia"},{"issue":"1\u20132","key":"10.1016\/j.cld.2024.01.004_bib44","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1016\/j.ejphar.2011.06.058","article-title":"Inhibition of NF-\u03baB by a PXR-dependent pathway mediates counter-regulatory activities of rifaximin on innate immunity in intestinal epithelial cells","volume":"668","author":"Mencarelli","year":"2011","journal-title":"Eur J Pharmacol"},{"issue":"4","key":"10.1016\/j.cld.2024.01.004_bib45","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1159\/000068362","article-title":"Inhibition of intestinal bacterial translocation with rifaximin modulates lamina propria monocytic cells reactivity and protects against inflammation in a rodent model of colitis","volume":"66","author":"Fiorucci","year":"2002","journal-title":"Digestion"},{"issue":"2","key":"10.1016\/j.cld.2024.01.004_bib46","doi-asserted-by":"crossref","first-page":"478","DOI":"10.1053\/j.gastro.2010.08.061","article-title":"Rifaximin improves driving simulator performance in a randomized trial of patients with minimal hepatic encephalopathy","volume":"140","author":"Bajaj","year":"2011","journal-title":"Gastroenterology"},{"issue":"4","key":"10.1016\/j.cld.2024.01.004_bib47","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0060042","article-title":"Modulation of the metabiome by rifaximin in patients with cirrhosis and minimal hepatic encephalopathy","volume":"8","author":"Bajaj","year":"2013","journal-title":"PLoS One"},{"issue":"9","key":"10.1016\/j.cld.2024.01.004_bib48","first-page":"1008","article-title":"Colon cleansing for diagnostic and surgical procedures: polyethylene glycol-electrolyte lavage solution","volume":"84","author":"DiPalma","year":"1989","journal-title":"Am J Gastroenterol"},{"issue":"11","key":"10.1016\/j.cld.2024.01.004_bib49","doi-asserted-by":"crossref","first-page":"1727","DOI":"10.1001\/jamainternmed.2014.4746","article-title":"Lactulose vs polyethylene glycol 3350--electrolyte solution for treatment of overt hepatic encephalopathy: the HELP randomized clinical trial","volume":"174","author":"Rahimi","year":"2014","journal-title":"JAMA Intern Med"},{"issue":"12","key":"10.1016\/j.cld.2024.01.004_bib50","doi-asserted-by":"crossref","first-page":"1476","DOI":"10.1097\/MEG.0000000000001267","article-title":"Randomized controlled trial of polyethylene glycol versus lactulose for the treatment of overt hepatic encephalopathy","volume":"30","author":"Shehata","year":"2018","journal-title":"Eur J Gastroenterol Hepatol"},{"issue":"1","key":"10.1016\/j.cld.2024.01.004_bib51","doi-asserted-by":"crossref","first-page":"12","DOI":"10.15171\/mejdd.2016.46","article-title":"Polyethylene glycol and lactulose versus lactulose Alone in the treatment of hepatic encephalopathy in patients with cirrhosis: a non-Inferiority randomized controlled trial","volume":"9","author":"Naderian","year":"2017","journal-title":"Middle East J Dig Dis"},{"issue":"1","key":"10.1016\/j.cld.2024.01.004_bib52","doi-asserted-by":"crossref","first-page":"e11","DOI":"10.1097\/MCG.0000000000001450","article-title":"Combined PEG3350 Plus lactulose results in early resolution of hepatic encephalopathy and improved 28-day survival in Acute-on-chronic liver Failure","volume":"56","author":"Ahmed","year":"2022","journal-title":"J\u00a0Clin Gastroenterol"},{"issue":"6","key":"10.1016\/j.cld.2024.01.004_bib53","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1016\/j.dld.2010.10.015","article-title":"Gut microbiota and probiotics in chronic liver diseases","volume":"43","author":"Cesaro","year":"2011","journal-title":"Dig Liver Dis"},{"issue":"2","key":"10.1016\/j.cld.2024.01.004_bib54","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1007\/s11011-013-9388-0","article-title":"Gut microbiota and hepatic encephalopathy","volume":"28","author":"Dhiman","year":"2013","journal-title":"Metab Brain Dis"},{"issue":"Suppl 1","key":"10.1016\/j.cld.2024.01.004_bib55","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1007\/s12072-017-9798-x","article-title":"Gut-liver axis, cirrhosis and portal hypertension: the chicken and the egg","volume":"12","author":"Arab","year":"2018","journal-title":"Hepatol Int"},{"issue":"11","key":"10.1016\/j.cld.2024.01.004_bib56","doi-asserted-by":"crossref","first-page":"3259","DOI":"10.1007\/s10620-006-9687-y","article-title":"Bifidobacterium longum with fructo-oligosaccharide (FOS) treatment in minimal hepatic encephalopathy: a randomized, double-blind, placebo-controlled study","volume":"52","author":"Malaguarnera","year":"2007","journal-title":"Dig Dis Sci"},{"issue":"7","key":"10.1016\/j.cld.2024.01.004_bib57","doi-asserted-by":"crossref","first-page":"1707","DOI":"10.1111\/j.1572-0241.2008.01861.x","article-title":"Probiotic yogurt for the treatment of minimal hepatic encephalopathy","volume":"103","author":"Bajaj","year":"2008","journal-title":"Am J Gastroenterol"},{"issue":"3","key":"10.1016\/j.cld.2024.01.004_bib58","doi-asserted-by":"crossref","first-page":"634","DOI":"10.4254\/wjh.v14.i3.634","article-title":"Effect of a specific Escherichia coli Nissle 1917 strain on minimal\/mild hepatic encephalopathy treatment","volume":"14","author":"Manzhalii","year":"2022","journal-title":"World J Hepatol"},{"issue":"5","key":"10.1016\/j.cld.2024.01.004_bib59","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1016\/j.amjms.2018.08.010","article-title":"Current evidence in Delivery and therapeutic Uses of fecal microbiota transplantation in human diseases-Clostridium difficile disease and beyond","volume":"356","author":"Stripling","year":"2018","journal-title":"Am J Med Sci"},{"issue":"5","key":"10.1016\/j.cld.2024.01.004_bib60","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1056\/NEJMoa1205037","article-title":"Duodenal infusion of donor feces for recurrent Clostridium difficile","volume":"368","author":"van Nood","year":"2013","journal-title":"N\u00a0Engl J Med"},{"issue":"5","key":"10.1016\/j.cld.2024.01.004_bib61","doi-asserted-by":"crossref","first-page":"940","DOI":"10.1016\/j.jhep.2013.12.019","article-title":"Altered profile of human gut microbiome is associated with cirrhosis and its complications","volume":"60","author":"Bajaj","year":"2014","journal-title":"J\u00a0Hepatol"},{"issue":"6","key":"10.1016\/j.cld.2024.01.004_bib62","doi-asserted-by":"crossref","first-page":"1727","DOI":"10.1002\/hep.29306","article-title":"Fecal microbiota transplant from a rational stool donor improves hepatic encephalopathy: a randomized clinical trial","volume":"66","author":"Bajaj","year":"2017","journal-title":"Hepatology"},{"issue":"6","key":"10.1016\/j.cld.2024.01.004_bib63","doi-asserted-by":"crossref","first-page":"1921","DOI":"10.1053\/j.gastro.2019.01.033","article-title":"Long-term outcomes of fecal microbiota transplantation in patients with cirrhosis","volume":"156","author":"Bajaj","year":"2019","journal-title":"Gastroenterology"},{"issue":"5","key":"10.1016\/j.cld.2024.01.004_bib64","doi-asserted-by":"crossref","first-page":"1690","DOI":"10.1002\/hep.30690","article-title":"Fecal microbial transplant capsules are safe in hepatic encephalopathy: a Phase 1, randomized, placebo-controlled trial","volume":"70","author":"Bajaj","year":"2019","journal-title":"Hepatology"},{"issue":"5","key":"10.1016\/j.cld.2024.01.004_bib65","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1111\/j.1365-2362.1988.tb01053.x","article-title":"Ammonia and glutamine metabolism in human liver slices: new aspects on the pathogenesis of hyperammonaemia in chronic liver disease","volume":"18","author":"Kaiser","year":"1988","journal-title":"Eur J Clin Invest"},{"issue":"2","key":"10.1016\/j.cld.2024.01.004_bib66","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1002\/hep.1840130208","article-title":"Functional hepatocyte heterogeneity in glutamate, aspartate and alpha-ketoglutarate uptake: a histoautoradiographical study","volume":"13","author":"Stoll","year":"1991","journal-title":"Hepatology"},{"issue":"1","key":"10.1016\/j.cld.2024.01.004_bib67","first-page":"1","article-title":"Treatment of cirrhotic rats with L-ornithine-L-aspartate enhances urea synthesis and lowers serum ammonia levels","volume":"283","author":"Gebhardt","year":"1997","journal-title":"J\u00a0Pharmacol Exp Ther"},{"issue":"6","key":"10.1016\/j.cld.2024.01.004_bib68","doi-asserted-by":"crossref","first-page":"1351","DOI":"10.1002\/hep.510250609","article-title":"Therapeutic efficacy of L-ornithine-L-aspartate infusions in patients with cirrhosis and hepatic encephalopathy: results of a placebo-controlled, double-blind study","volume":"25","author":"Kircheis","year":"1997","journal-title":"Hepatology"},{"issue":"8","key":"10.1016\/j.cld.2024.01.004_bib69","doi-asserted-by":"crossref","first-page":"725","DOI":"10.1097\/MEG.0b013e32834696f5","article-title":"A\u00a0randomized controlled trial comparing lactulose, probiotics, and L-ornithine L-aspartate in treatment of minimal hepatic encephalopathy","volume":"23","author":"Mittal","year":"2011","journal-title":"Eur J Gastroenterol Hepatol"},{"issue":"4","key":"10.1016\/j.cld.2024.01.004_bib70","doi-asserted-by":"crossref","first-page":"225","DOI":"10.4103\/1319-3767.136975","article-title":"Effect of rifaximin, probiotics, and l-ornithine l-aspartate on minimal hepatic encephalopathy: a randomized controlled trial","volume":"20","author":"Sharma","year":"2014","journal-title":"Saudi J Gastroenterol"},{"issue":"5","key":"10.1016\/j.cld.2024.01.004_bib71","first-page":"CD012410","article-title":"L-ornithine L-aspartate for prevention and treatment of hepatic encephalopathy in people with cirrhosis","volume":"5","author":"Goh","year":"2018","journal-title":"Cochrane Database Syst Rev"},{"issue":"5","key":"10.1016\/j.cld.2024.01.004_bib72","first-page":"CD001939","article-title":"Branched-chain amino acids for people with hepatic encephalopathy","volume":"5","author":"Gluud","year":"2017","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.cld.2024.01.004_bib73","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1016\/S0168-8278(05)80210-7","article-title":"Long-term treatment of latent portosystemic encephalopathy with branched-chain amino acids. A double-blind placebo-controlled crossover study","volume":"17","author":"Plauth","year":"1993","journal-title":"J\u00a0Hepatol"}],"container-title":["Clinics in Liver Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1089326124000047?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1089326124000047?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,3,27]],"date-time":"2024-03-27T05:41:34Z","timestamp":1711518094000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1089326124000047"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,5]]},"references-count":73,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2024,5]]}},"alternative-id":["S1089326124000047"],"URL":"https:\/\/doi.org\/10.1016\/j.cld.2024.01.004","relation":{},"ISSN":["1089-3261"],"issn-type":[{"value":"1089-3261","type":"print"}],"subject":[],"published":{"date-parts":[[2024,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Minimal Hepatic Encephalopathy","name":"articletitle","label":"Article Title"},{"value":"Clinics in Liver Disease","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.cld.2024.01.004","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}